Pancreatic cancer remains one of the most lethal malignancies worldwide, with five-year survival rates hovering around 10% and median survival often measured in months rather than years. The majority of patients present with…
Therapeutic Vaccines in Pancreatic Cancer: Challenging a Historically Immune-Resistant Disease
